Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Sales and DivestituresNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Relay Therapeutics (RLAY) Net Income: 2019-2024

Historic Net Income for Relay Therapeutics (RLAY) over the last 6 years, with Dec 2024 value amounting to -$337.7 million.

  • Relay Therapeutics' Net Income rose 16.02% to -$74.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$296.8 million, marking a year-over-year increase of 14.03%. This contributed to the annual value of -$337.7 million for FY2024, which is 1.24% up from last year.
  • Relay Therapeutics' Net Income amounted to -$337.7 million in FY2024, which was up 1.24% from -$342.0 million recorded in FY2023.
  • Over the past 5 years, Relay Therapeutics' Net Income peaked at -$52.4 million during FY2020, and registered a low of -$363.9 million during FY2021.
  • Moreover, its 3-year median value for Net Income was -$337.7 million (2024), whereas its average is -$323.4 million.
  • Per our database at Business Quant, Relay Therapeutics' Net Income surged by 30.40% in 2020 and then slumped by 594.25% in 2021.
  • Over the past 5 years, Relay Therapeutics' Net Income (Yearly) stood at -$52.4 million in 2020, then slumped by 594.25% to -$363.9 million in 2021, then rose by 20.17% to -$290.5 million in 2022, then fell by 17.72% to -$342.0 million in 2023, then rose by 1.24% to -$337.7 million in 2024.